4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000026
Director sold 450,000 shares at an average $6.52 ($2,932,500)
- Director acquired 450,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KRIEGSMAN STEVEN A · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-01-17 | Exercise or conversion : show line 1 in the form | +200,000 | $0.85 | $170,000 | 205,000 | D |
| 2014-01-17 | Sale : show line 2 in the form | −200,000 | $7.00 | $1,400,000 | 5,000 | D |
| 2014-01-22 | Exercise or conversion : show line 3 in the form | +200,000 | $1.18 | $236,000 | 205,000 | D |
| 2014-01-22 | Exercise or conversion : show line 4 in the form | +50,000 | $0.72 | $36,000 | 255,000 | D |
| 2014-01-22 | Sale : show line 5 in the form | −250,000 | $6.13 | $1,532,500 | 5,000 | D |
| Open-market sales · 450,000 sh · avg $6.52 · $2,932,500 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-01-17 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −200,000 | 0 | D |
| 2014-01-22 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −200,000 | 0 | D |
| 2014-01-22 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −50,000 | 0 | D |
Loading xslF345X03/primary_doc.xml…